July 2021
2021
31/07/2021
July Newsletter 2021
23/07/2021
6PR (Audio) – Proteomics: Predicting a disease before you get it – now that’s novel
22/07/2021
Proteomics International engages Abcam to manufacture PromarkerD reagents – Proactive Investors
22/07/2021
Proteomics engages Abcam to manufacture PromarkerD reagents
20/07/2021
Investor Presentation – Non-deal Roadshow
16/07/2021
Proteomics International Laboratories (ASX:PIQ) shows diabetes drug improves PromarkerD risk scores – The Market Herald
16/07/2021
Diabetes treatment lowers PromarkerD risk score: Results to be presented at Australasian Diabetes Conference
12/07/2021
PromarkerD at the Australasian Diabetes Congress
Newsroom
Private: In the Media
Presentations
Newsletters
Publications
Events
News Archive
2022
2021
2020
2019
2018
2017
2016
2015
2014
2013
2012
2011
2010
Subscribe
Title
Name
*
Position
Company/Organisation
*
Phone
Email
*
Terms & Conditions
*
I accept the terms and conditions
Name
This field is for validation purposes and should be left unchanged.
Company
About Us
Board
Clinical Advisory Board
Mission Statement
Senior Staff
Quality
Customer Testimonials
Careers
Glossary
PromarkerD
Diagnostics
Biomarker Discovery
The Promarker™ Pipeline
Analytical Services
Pharmacokinetic Testing
Biosimilars/Biologics Drug Characterisation
Proteome Mapping
Proteome Quantitation (iTRAQ, TMT, Label-Free)
Targeted Mass Spectrometry (MRM/SRM)
Protein ID by Mass Spectrometry
Post-translational Modifications (PTMs)
Additional Services
Project Consultation
Pricing and Ordering
Terms and Conditions
FAQs
Newsroom
Media Releases
Media Coverage
Videos
Science & Technology
Presentations
Newsletters
Publications
Events
Investors
Share Price and Analyst Coverage
ASX Announcements
Corporate Media
Corporate Presentations
Library
Reports
Corporate Governance
Shareholder Information
Annual General Meeting
Contact
Sample Delivery
Technical
Business Development
Agents
